ARTICLE | Company News
Elite, Purdue Pharma deal
May 17, 2004 7:00 AM UTC
ELI's Elite Laboratories subsidiary granted Purdue exclusive rights to evaluate certain ELI abuse resistance drug formulation technology. Purdue also has an exclusive option to a license to develop an...